Table 3.
Multivariate Cox Proportional Hazard Model for 10-Year Disease-Free Survival (DFS) using 1D5 or SP1 to determine ER Status
| ER Status determined by 1D5 n = 225 | ER Status determined by SP1 n = 225 | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| Characteristic | HR | 95% CI | P | HR | 95% CI | P |
| Age at diagnosis, years | ||||||
| <50 vs.≥50 | 0.990 | 0.607–1.615 | 0.9676 | 0.976 | 0.597–1.595 | 0.9220 |
| Nodal status | ||||||
| Positive vs. negative | 0.481 | 0.308–0.752 | 0.0013 | 0.475 | 0.303–0.744 | 0.0012 |
| Tumor size, mm | ||||||
| ≤2 vs. ≥5 | 0.287 | 0.160–0.516 | < 0.0001 | 0.308 | 0.171–0.556 | < 0.0001 |
| 2–5 vs. ≥5 | 0.483 | 0.292–0.799 | 0.0046 | 0.488 | 0.294–0.810 | 0.0055 |
| Nuclear Grade | ||||||
| 1 vs. 3 | 0.855 | 0.430–1.700 | 0.6547 | 0.887 | 0.441–1.783 | 0.7365 |
| 2 vs. 3 | 0.983 | 0.617–1.564 | 0.9413 | 0.963 | 0.603–1.538 | 0.8745 |
| ER status | ||||||
| Positive vs. negative | 1.943 | 1.230–3.069 | 0.0044 | 1.994 | 1.220–3.259 | 0.0059 |
Overall model is significant with 1D5 (Chi-Square = 44.169, Wald P-value = <0.0001) and with SP1 (Chi-Square = 44.319, Wald P-value = <0.0001). ER, estrogen receptor; HR, adjusted hazard ratio; DFS, disease-free survival